Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: ADC, Astrazeneca, Bio-Thera Solutions, Canbridge, Glenmark, Humanigen, Hutchmed, Moderna, Propanc, Sanotize R&D, Telix, Tetra.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Abbisko, Arctic Vision, Ascletis, Humanigen, Hutchmed, Inmagene, JW, Moleculin, Obi, Sunho, Takeda, Veru.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Arrowhead, Ascletis, Astellas, Biontech, Canariabio, Clover, H. Lundbeck, Otsuka, Pfizer, Takeda, Todos Medical.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: 60 Degrees, Akston, Bharat, Biolexis, GSK, Innocare, Kinarus, Moderna, Ocugen, Recce, Sanofi.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Actinogen Medical, Bavarian Nordic, Clover, Curocell, Daiichi Sankyo, Dompe, Genexine, GSK, Kangpu, Moleculin, Pfizer, Prothione, Puretech Health, Sanofi, Sinomab, Sirnaomics, Zhimeng.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Astrazeneca, Brii, Immunome, Innocare, Kazia, Keymed, Medicinova, Merck, Moderna, Ridgeback, Rigel, Takeda, Tevogen.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Acelyrin, Adamis, Affamed, Affibody, Alterity, Anji, Antengene, Biogen, Biothera Solutions, Bristol Myers Squibb, Celltrion Healthcare, Clover, I-Mab, Incannex Healthcare, Inmagene, Kazia, Megakaryon, NLC, Olix, Relief, Samsung Bioepis, Sirnaomics, Sorrento, Taurx, Todos Medical.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Antengene, Axcella Health, Biontech, Codagenix, Edesa, Harbour, Junshi, Laekna, Moleculin, Pfizer, Visen.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Anji, Athersys, Belief Biomed, China Oncology Focus, Cstone, Healios, Imugene, Prota, Recce, Regencell, Sorrento, Synairgen, Urovant Sciences.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Adocia, Akston, Bio-Thera Solutions, Bridge, Carsgen, Clinuvel, Dizal, Hua Medicine, Hyundai, Inovio, Lianbio, Tonghua Dongbao, Zhimeng.